No black box warning on record for Herceptin Hylecta
As of the latest FDA labeling reviewed, Herceptin Hylecta (TRASTUZUMAB AND HYALURONIDASE-OYSK) does not carry a black box warning. Standard warnings and precautions still apply — see the full Herceptin Hylecta medicine page for the complete safety profile.